
    
      This study is a prospective, randomized, controlled clinical trials. 300 patients were
      randomly divided into 2 groups for its own control study.

      Test group: Zhen qishen capsule (2 capsules, Bid) and Oral Supplement of Yuyikang (50g,Bid),
      a total of 150 people, are used for 42 days continuously.

      Placebo group: Zhen qishen capsule placebo (2 capsules, Bid) and Oral Supplement of Yuyikang
      placebo (50g, Bid), a total of 150 people, are used for 42 days continuously.

      The subjects were randomized to AB or BA parallely, and the two groups were given
      chemotherapy and nutrition.
    
  